Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
NCT01127295
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2000
Enrollment
OTHER
Sponsor class
Conditions
Hormono-depending Adjuvant Breast Cancer
Interventions
DRUG:
Tamoxifen, Letrozole, Anastrozole or Exemestane
Sponsor
Institut Claudius Regaud